Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

The present invention relates to a novel process for preparing ceftaroline fosamil as well as to intermediates of this process.

One objective of the present invention is to provide an organic EL element which is suppressed in change in the resistance of a light emitting layer after passing a current therethrough for a long period of time, thereby having good emission spectrum chromaticity, and which is suppressed in change in the emission characteristics over time. Another objective of the present invention is to provide a lighting device and a display device, each of which uses the organic EL element. An organic electroluminescent element of the present invention is provided with a pair of electrodes and one or more organic layers that are arranged between the pair of electrodes, and is characterized in that one or more layers among the organic layers contain a compound that has a structure represented by general formula (1).

Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

A method and antisense compound for inhibiting the growth of pathogenic bacterial cells are disclosed. The compound contains no more than 12 nucleotide bases and has a targeting nucleic acid sequence of no fewer than 10 bases in length that is complementary to a target sequence containing or within 10 bases, in a downstream direction, of the translational start codon of a bacterial mRNA that encodes a bacterial protein essential for bacterial replication. The compound binds to a target mRNA with a T.sub.m of between 50 to 60 C. The relatively short antisense compounds are substantially more active than conventional antisense compounds having a targeting base sequence of 15 or more bases.

The present invention relates to novel crystalline forms of ceftaroline fosamil and to methods for their preparation. Furthermore the present invention relates to the use of the novel forms of ceftaroline fosamil for the preparation of an antibiotic medicament. In addition the present invention relates to pharmaceutical compositions comprising an effective amount of the novel forms of ceftaroline fosamil and to methods of preparing the same. Finally the present invention relates to pharmaceutical combinations comprising an effective amount of the novel forms of ceftaroline fosamil and -lactamase inhibitors.